approval
saveOZURDEX (DEXAMETHASONE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalMar 11, 2026 · 209d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalDec 19, 2022 · 1387d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalOct 21, 2020 · 2176d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalMay 15, 2018 · 3066d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalFeb 5, 2016 · 3896d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalSep 26, 2014 · 4393d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalFeb 7, 2014 · 4624d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalSep 7, 2012 · 5142d ago
same company · ±60 days · 6
- approvallinaclotide: LINZESS (LINACLOTIDE) — FDA approvalJul 1, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJun 20, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJun 19, 2014
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJun 19, 2014
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalJun 19, 2014
- approvallinaclotide: LINZESS (LINACLOTIDE) — FDA approvalJul 9, 2014
comments(0)
5-min edit window · permanent after that